World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03454594
Date of registration: 25/02/2018
Prospective Registration: Yes
Primary sponsor: Cairo University
Public title: Watch Laser Acupuncture With Nasal Radiation for Prevention of Coronary Artery Disease
Scientific title: Laser Hemotherapy Trial for Coronary Artery Disease Prevention in High Risk Patients
Date of first enrolment: May 1, 2018
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03454594
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Egypt
Contacts
Name:     Cairo Giza, MD
Address: 
Telephone:
Email:
Affiliation:  Cairo University
Key inclusion & exclusion criteria

Inclusion Criteria:

- stage I hypertensive patients

- patients from 30 to 34.9 kg/m2 body mass index

- medically stable patients

- all participants have sufficient cognition enough to understand the requirements of
the study

Exclusion Criteria:

- history of malignant disease

- smoking

- history of progressive fatal disease

- history of drug or alcohol abuse

- blood donation within at least 30 days

- pregnant, trying to be pregnant or breast feeding

- cognitive impairment that will make it difficult to partake in the study



Age minimum: 55 Years
Age maximum: 65 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Cardiovascular Risk Factor
Coronary Artery Disease
Intervention(s)
Device: low level laser hemotherapy
Primary Outcome(s)
changes of blood pressure [Time Frame: 8 weeks]
Secondary Outcome(s)
change in HDL (high density lipoprotien) level [Time Frame: 60 days]
changes in blood viscosity [Time Frame: 8 weeks]
change in IL-17 level [Time Frame: 45 days]
change in LDL (low density lipoprotien) level [Time Frame: 60 days]
change in CD 8 (cluster of differentiation 8) level [Time Frame: 45 days]
change in TG (triglyceride) level [Time Frame: 60 days]
change in TC (total cholesterol) level [Time Frame: 60 days]
change in functional capacity [Time Frame: 70 days]
Secondary ID(s)
P.T.REC/012/001561
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history